Papers

3 results
Xiao-ai-ping injection adjunct with platinum-based chemotherapy for advanced non-small-cell lung cancer: a systematic review and meta-analysis.
Feng F, Huang J, Wang Z, Zhang J, Han D, Wu Q, He H, Zhou X - BMC complementary medicine and therapies, February 06, 2020 14 citations
P
NSCLC patients
I/C
Xiao-ai-ping injection (XAPI) + platinum-based chemotherapy, platinum-based chemotherapy alone
O
objective tumor response rate (ORR), Karnofsky performance scores (KPS), occurrence of grade 3/4 leukopenia, anemia, thrombocytopenia, nausea and vomiting, immune function (CD8)
Current standard values of health utility scores for evaluating cost-effectiveness in liver disease: A meta-analysis.
Ishinuki T, Ota S, Harada K, Kawamoto M, Meguro M, Kutomi G, Tatsumi H, Harada K, Miyanishi K, Kato T, Ohyanagi T, Hui TT, Mizuguchi T - World journal of gastroenterology, September 27, 2022 0 citations
P
chronic liver disease, hepatitis C, hepatitis B
I/C
antiviral therapy, hepatitis B, hepatitis C
O
health utility scores
P
Orthodontic-surgical treatment patients
I/C
Conventional combined orthodontic-surgical treatment, No treatment or alternative treatments
O
Oral health-related quality of life
CEO: Hwi-yeol YunCOO: Jung-woo ChaeCTO: Sangkeun Jung
Location: 204, W6, Chungnam National University, 99, Daehak-ro, Yuseong-gu, Daejeon, Republic of Korea
Tel: 042-821-7328E-mail: webmaster@lilac-co.kr
Copyright © 2024 by LiLac. All Rights Reserved.